Background:
Ovarian cancer is the second commonest gynecological malignancy, the fifth commonest cancer affecting women in the developed world, and the leading indication for gynecologicaloncological surgery. There is a wide range of management options for ovarian cancers from conservative to radical surgery; conservative laparoscopic surgery in young women wishing to preserve their childbearing potential (borderline epithelial tumors) is the preferred method. The current investigation tool for management of ovarian masses consist of a TVS as the screening tool and determining the RMI using US score, menopausal state and CA 125 levels. MRI with Gd is the next preferred method, while it keeps indeterminate masses which are managed intra-operatively using macroscopic and histological frozen section analysis of vegetations or solid tumor components. Several studies have emphasized the diagnostic performance of new imaging modalities such as dynamic contrast enhanced MRI (DCE-MRI) as well as their DWI and MRS findings in the determination of adnexal masses.